Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-16

Clinical Trial Update: A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating a combination intraocular pressure-lowering therapy in open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Open-angle, Ocular Hypertension | Phase 2 | Status: COMPLETED